New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen

Virus Research

Volumn 211, Issue , 2016, Pages 209-221

  Kucinskaite Kodze, Indre ^a   Pleckaityte, Milda ^a   Bremer, Corinna M ^b   Seiz, Pia L ^b   Zilnyte, Milda ^a   Bulavaite, Aiste ^a   Mickiene, Gitana ^a   Zvirblis, Gintautas ^a   Sasnauskas, Kestutis ^a   Glebe, Dieter ^b   Zvirbliene, Aurelija ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Epitope mapping; HBsAg; Hepatitis B virus; Monoclonal antibodies; ScFv

Indexed keywords

ALANINE; AMINO ACID; EPITOPE; HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; HEPATITIS B ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS REACTION; DNA SEQUENCE; EPITOPE MAPPING; ESCHERICHIA COLI; HEPATITIS B VIRUS; HEPATITIS B VIRUS GENOTYPE A; HEPATITIS B VIRUS GENOTYPE B; HEPATITIS B VIRUS GENOTYPE C; HEPATITIS B VIRUS GENOTYPE D; HUMAN; HUMAN CELL; HYBRIDOMA; MOLECULAR INTERACTION; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN; WESTERN BLOTTING; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; HEPATITIS B; IMMUNOLOGY; MOLECULAR GENETICS; VIROLOGY;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; EPITOPE MAPPING; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 84951794512     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.10.024     Document Type: Article

References (93)

1. Abou-Jaoudé G., Sureau C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. J. Virol. 2007, 81:13057-13066.
2. Abou-Jaoudé G., Sureau C. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J. Virol. 2005, 79:10460-10466.
3. Alves Vianna C.O., da Silva Mouta Júnior E.S., da Glória Teixeira Martins M., Batoreu N.M., Queiroz J.L., Gomes S.A., Magalhães de Andrade Góes A.C., Garcia Armoa G.R., Marques C.H., Baroni de Moraes M.T. Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches. J. Immunol. Methods 2006, 313:38-47.
4. Andersen D.C., Reilly D.E. Production technologies for monoclonal antibodies and their fragments. Curr. Opin. Biotechnol. 2004, 15:456-462.
5. Ashton-Rickardt P.G., Murray K. Mutations that change the immunological subtype of hepatitis B virus surface antigen and distinguish between antigenic and immunogenic determination. J. Med. Virol. 1989, 29:204-214.
6. Bahn A., Gerner P., Martiné U., Bortolotti F., Wirth S. Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence. J. Hepatol. 1997, 27:973-978.
7. Beale M.A., Ijaz S., Tedder R.S. The genetic backbone modulates the phenotype of hepatitis B surface antigen mutants. J. Gen. Virol. 2010, 91:68-73.
8. Benhar I., Pastan I. Identification of residues that stabilize the single-chain Fv of monoclonal antibodies B3. J. Biol. Chem. 1995, 270:23373-23380.
9. Ben-Porath E., Wands J.R., Marciniak R.A., Wong M.A., Hornstein L., Ryder R., Canlas M., Lingao A., Isselbacher K.J. Structural analysis of hepatitis B Surface antigen by monoclonal antibodies. J. Clin. Invest. 1985, 76:1338-1347.
10. Bhatnagar P.K., Papas E., Blum H.E., Milich D.R., Nitecki D., Karels M.J., Vyas G.N. Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:4400-4404.
11. Bichko V., Pushko P., Dreilina D., Pumpen P., Gren E. Subtype ayw variant of hepatitis B virus. DNA primary structure analysis. FEBS Lett. 1985, 185:208-212.
12. Block T.M., Guo H., Guo J.-T. Molecular virology of hepatitis B virus for clinicians. Clin. Liver Dis. 2007, 11:685-706.
13. Bremer C.M., Sominskaya I., Skrastina D., Pumpens P., El Wahed A.A., Beutling U., Frank R., Fritz H.-J., Hunsmann G., Gerlich W.H., Glebe D. N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus. J. Hepatol. 2011, 55:29-37.
14. Brown S.E., Howard C.R., Steward M.W., Ajdukiewicz A.B., Whittle H.C. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients. Clin. Exp. Immunol. 1984, 55:355-359.
15. Carman W.F., Korula J., Wallace L., MacPhee R., Mimms L., Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995, 345:1406-1407.
16. Cerino A., Bremer C.M., Glebe D., Mondelli M.U. A human monoclonal antibody against hepatitis B surface antigen with potent neutralizing activity. PLoS One 2015, 10:e0125704.
17. Chudy M., Hanschmann K.-M., Kress J., Nick S., Campos R., Wend U., Gerlich W., Nübling C.M. First WHO international reference panel containing hepatitis B virus genotypes A-G for assays of the viral DNA. J. Clin. Virol. 2012, 55:303-309.
18. Coleman P.F., Chen Y.C., Mushahwar I.K. Immunoassay detection of hepatitis B surface antigen mutants. J. Med. Virol. 1999, 59:19-24.
19. Couroucé A.M., Lee H., Drouet J., Canavaggio M., Soulier J.P. Monoclonal antibodies to HBsAg: a study of their specificities for eight different HBsAg subtypes. Dev. Biol. Stand. 1983, 54:527-534.
20. De Marco A. Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs. Microb. Cell Fact. 2015, 14. 125.
21. de Vries S.J., van Dijk M., Bonvin A.M.J.J. The HADDOCK web server for data-driven biomolecular docking. Nat. Protoc. 2010, 5:883-897.
22. Dreesman G.R., Sanchez Y., Ionescu-Matiu I., Sparrow J.T., Six H.R., Peterson D.L., Hollinger F.B., Melnick J.L. Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature 1982, 295:158-160.
23. El Chaar M., Candotti D., Crowther R.A., Allain J.P. Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology 2010, 52:1600-1610.
24. Gasteiger E., Hoogland C., Gattiker A., Wilkins M.R., Appel R.D., Bairoch A. Protein identification and analysis tools on the ExPASy server. The Proteomics Protocols Handbook 2005, 571-607. Humana Press. J.M. Walker (Ed.).
25. Gerlich W.H. Medical virology of hepatitis B: how it began and where we are now. Virol. J. 2013, 10:239.
26. Ghany M.G., Ayola B., Villamil F.G., Gish R.G., Rojter S., Vierling J.M., Lok A.S. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998, 27:213-222.
27. Glebe D., Urban S., Knoop E.V., Çağ N., Krass P., Grün S., Bulavaite A., Sasnauskas K., Gerlich W.H. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting pres1 lipopeptides and tupaia hepatocytes. Gastroenterology 2005, 129:234-245.
28. Golsaz Shirazi F., Mohammadi H., Amiri M.M., Singethan K., Xia Y., Bayat A.A., Bahadori M., Rabbani H., Jeddi-Tehrani M., Protzer U., Shokri F. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection. J. Gastroenterol. Hepatol. 2014, 29:1083-1091.
29. Gong R., Vu B.K., Feng Y., Prieto D.A., Dyba M.A., Walsh J.D., Prabakaran P., Veenstra T.D., Tarasov S.G., Ishima R., Dimitrov D.S. Engineered human antibody constant domains with increased stability. J. Biol. Chem. 2009, 284:14203-14210.
30. Goodall A.H., Meek F.L., Waters J.A., Miescher G.C., Janossy G., Thomas H.C. A rapid one-step radiometric assay for hepatitis B surface antigen utilizing monoclonal antibodies. J. Immunol. Methods 1982, 52:167-174.
31. Horsfall A.C., Hay F.C., Soltys A.J., Jones M.G. Epitope mapping. Immunol. Today 1991, 12:211-213.
32. Hou J., Karayiannis P., Waters J., Luo K., Liang C., Thomas H.C. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 1995, 21:273-278.
33. Huang X., Lu D., Ji G., Sun Y., Ma L., Chen Z., Zhang L., Huang J., Yu L. Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China. Virus Res. 2004, 99:63-68.
34. Yamamoto K., Horikita M., Tsuda F., Itoh K., Akahane Y., Okamoto H., Miyakawa Y., Mayumi M. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J. Virol. 1994, 68:2671-2676.
35. Yan H., Zhong G., Xu G., He W., Jing Z., Gao Z., Huang Y., Qi Y., Peng B., Wang H., Fu L., Song M., Chen P., Gao W., Ren B., Sun Y., Cai T., Feng X., Sui J., Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012, 1:e00049.
36. Ijaz S. A first loop linear epitope accessible on native hepatitis B surface antigen that persists in the face of second loop immune escape. J. Gen. Virol. 2003, 84:269-275.
37. Joosten V., Lokman C., Van Den Hondel C.A., Punt P.J. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb. Cell Fact. 2003, 2:1.
38. Julithe R., Abou-Jaoudé G., Sureau C. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies. J. Virol. 2014, 88:9049-9059.
39. Karthigesu V.D., Allison L.M., Fortuin M., Mendy M., Whittle H.C., Howard C.R. A novel hepatitis B virus variant in the sera of immunized children. J. Gen. Virol. 1994, 75(Pt. 2):443-448.
40. Kfoury Baz E.M., Zheng J., Mazuruk K., Van Le A., Peterson D.L. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays. Transfus. Med. 2001, 11:355-362.
41. Kim S.-H., Shin Y.W., Hong K.-W., Chang K.-H., Ryoo K.-H., Paik S.-H., Kim J.-M., Brotman B., Pfahler W., Prince A.M. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees. Antiviral Res. 2008, 79:188-191.
42. Klatt S., Konthur Z. Secretory signal peptide modification for optimized antibody-fragment expression-secretion in Leishmania tarentolae. Microb. Cell Fact. 2012, 11:97.
43. König A., Döring B., Mohr C., Geipel A., Geyer J., Glebe D. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes. J. Hepatol. 2014, 61:867-875.
44. Laskowski R.A., Moss D.S., Thornton J.M. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 1993, 231:1049-1067.
45. Leistner C.M., Gruen-Bernhard S., Glebe D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell. Microbiol. 2008, 10:122-133.
46. Mangold C.M., Unckell F., Werr M., Streeck R.E. Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 1995, 211:535-543.
47. Marcatili P., Rosi A., Tramontano A. PIGS: automatic prediction of antibody structures. Bioinformatics 2008, 24:1953-1954.
48. Moutel S., El Marjou A., Vielemeyer O., Nizak C., Benaroch P., Dübel S., Perez F. A multi-Fc-species system for recombinant antibody production. BMC Biotechnol. 2009, 9:14.
49. Ngui S.L., O'Connell S., Eglin R.P., Heptonstall J., Teo C.G. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J. Infect. Dis. 1997, 176:1360-1365.
50. Norder H., Couroucé A.-M., Magnius L.O. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J. Gen. Virol. 1992, 73(Pt. 12):3141-3145.
51. Norder H., Couroucé A.-M., Coursaget P., Echevarria J.M., Lee S.-D., Mushahwar I.K., Robertson B.H., Locarnini S., Magnius L.O. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004, 47:289-309.
52. Olechnovič K., Venclovas C. Voronota: A fast and reliable tool for computing the vertices of the Voronoi diagram of atomic balls. J. Comput. Chem. 2014, 35:672-681.
53. Oon C.J., Lim G.K., Ye Z., Goh K.T., Tan K.L., Yo S.L., Hopes E., Harrison T.J., Zuckerman A.J. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995, 13:699-702.
54. Paulij W.P., de Wit P.L., Sünnen C.M., van Roosmalen M.H., Petersen-van Ettekoven A., Cooreman M.P., Heijtink R.A. Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen. J. Gen. Virol. 1999, 80(Pt. 8):2121-2126.
55. Peterson D.L., Paul D.A., Lam J., Tribby I.I., Achord D.T. Antigenic structure of hepatitis B surface antigen: identification of the d subtype determinant by chemical modification and use of monoclonal antibodies. J. Immunol. 1984, 132:920-927.
56. Petit M.A., Capel F., Riottot M.M., Dauguet C., Pillot J. Antigenic mapping of the surface proteins of infectious hepatitis B virus particles. J. Gen. Virol. 1987, 68(Pt. 11):2759-2767.
57. Pillot J., Riottot M.M., Geneste C., Phalente L., Mangalo R. Analysis of the vaccinating group specificity a of HBsAg with monoclonal antibodies. Identification of continuous and discontinuous epitopes. Dev. Biol. Stand. 1984, 57:299-304.
58. Pleckaityte M., Bremer C.M., Gedvilaite A., Kucinskaite-Kodze I., Glebe D., Zvirbliene A. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen. BMC Biotechnol. 2015, 15. 85.
59. Pleckaityte M., Mistiniene E., Lasickiene R., Zvirblis G., Zvirbliene A. Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis. BMC Biotechnol. 2011, 11:100.
60. Pleckaityte M., Zvirbliene A., Sezaite I., Gedvilaite A. Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin. Microb. Cell Fact. 2011, 10:109.
61. Protzer-Knolle U., Naumann U., Bartenschlager R., Berg T., Hopf U., Meyer zum Büschenfelde K.H., Neuhaus P., Gerken G. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998, 27:254-263.
62. Qiu X., Schroeder P., Bridon D. Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen. J. Immunol. 1996, 156:3350-3356.
63. Roohi A., Khoshnoodi J., Zarnani A.H., Shokri F. Epitope mapping of recombinant hepatitis B surface antigen by murine monoclonal antibodies. Hybridoma (Larchmt) 2005, 24:71-77.
64. Salisse J., Sureau C. A function essential to viral entry underlies the hepatitis B virus a determinant. J. Virol. 2009, 83:9321-9328.
65. Seddigh-Tonekaboni S., Waters J.A., Jeffers S., Gehrke R., Ofenloch B., Horsch A., Hess G., Thomas H.C., Karayiannis P. Effect of variation in the common a determinant on the antigenicity of hepatitis B surface antigen. J. Med. Virol. 2000, 60:113-121.
66. Seeger C., Mason W.S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 2000, 64:51-68.
67. Seo M.J., Jeong K.J., Leysath C.E., Ellington A.D., Iverson B.L., Georgiou G. Engineering antibody fragments to fold in the absence of disulfide bonds. Protein Sci. 2009, 18:259-267.
68. Shi W., Zhu C., Zheng W., Zheng W., Ling C., Carr M.J., Higgins D.G., Zhang Z. Subgenotyping of genotype C hepatitis B virus: correcting misclassifications and identifying a novel subgenotype. PLoS One 2012, 7:e47271.
69. Shin Y.-W., Ryoo K.-H., Hong K.-W., Chang K.-H., Choi J.-S., So M., Kim P.-K., Park J.-Y., Bong K.-T., Kim S.-H. Human monoclonal antibody against hepatitis B virus surface antigen (HBsAg). Antiviral Res. 2007, 75:113-120.
70. Simmonds P. The origin and evolution of hepatitis viruses in humans. J. Gen. Virol. 2001, 82(Pt. 4):693-712.
71. Sircar A. Methods for the homology modeling of antibody variable regions. Methods Mol. Biol. 2012, 857:301-311.
72. Skrastina D., Bulavaite A., Sominskaya I., Kovalevska L., Ose V., Priede D., Pumpens P., Sasnauskas K. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers. Vaccine 2008, 26:1972-1981.
73. Stirk H.J., Thornton J.M., Howard C.R. A topological model for hepatitis B surface antigen. Intervirology 1992, 33:148-158.
74. Stricker E.A., Tiebout R.F., Lelie P.N., Zeijlemaker W.P. A human monoclonal IgG1 lambda anti-hepatitis B surface antibody. Production, properties, and applications. Scand. J. Immunol. 1985, 22:337-343.
75. Su W.-J., Ho M.-C., Ni Y.-H., Wu J.-F., Jeng Y.-M., Chen H.-L., Wu Y.-M., Hu R.-H., Chang M.-H., Lee P.-H. Clinical course of de novo hepatitis B infection after pediatric liver transplantation. Liver Transpl. 2010, 16:215-221.
76. Sureau C., Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 2013, 57:985-994.
77. Tajiri K., Ozawa T., Jin A., Tokimitsu Y., Minemura M., Kishi H., Sugiyama T., Muraguchi A. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine. Antiviral Res. 2010, 87:40-49.
78. Tan W., Meng Y., Li H., Chen Y., Han S., Zeng J., Huang A., Li B., Zhang Y., Guo Y. A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity. MAbs 2013, 5:946-955.
79. Tian Y., Xu Y., Zhang Z., Meng Z., Qin L., Lu M., Yang D. The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J. Clin. Microbiol. 2007, 45:2971-2978.
80. Toplikar E., Carlomagno A., Rojkin L.F., Gariglio R., Lorenzo L.E. Development of an enzyme immunoassay for the detection of hepatitis B surface antigen employing monoclonal antibodies. J. Clin. Lab. Anal. 1993, 7:324-328.
81. van Roosmalen M.H., de Jong J.J., Haenen W., Jacobs T., Couwenberg F., Ahlers-de Boer G.J.C.M., Hellings J.A. A new HBsAg screening assay designed for sensitive detection of HBsAg subtypes and variants. Intervirology 2006, 49:127-132.
82. Vuori K., Pihlajaniemi T., Myllylä R., Kivirikko K.I. Site-directed mutagenesis of human protein disulphide isomerase: effect on the assembly: activity and endoplasmic reticulum retention of human prolyl 4-hydroxylase in Spodoptera frugiperda insect cells. EMBO J. 1992, 11:4213-4217.
83. Wands J.R., Wongt M.A., Shoreyt J., Brown R.D., Marciniak R.A., Isselbacher K.J. Hepatitis B viral antigenic structure: signature analysis by monoclonal radioimmunoassays. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:2237-2241.
84. Wassenaar T.A., van Dijk M., Loureiro-Ferreira N., van der Schot G., de Vries S.J., Schmitz C., van der Zwan J., Boelens R., Giachetti A., Ferella L., Rosato A., Bertini I., Herrmann T., Jonker H.R.A., Bagaria A., Jaravine V., Güntert P., Schwalbe H., Vranken W.F., Doreleijers J.F., Vriend G., Vuister G.W., Franke D., Kikhney A., Svergun D.I., Fogh R.H., Ionides J., Laue E.D., Spronk C., Jurkša S., Verlato M., Badoer S., Dal Pra S., Mazzucato M., Frizziero E., Bonvin A.M.J.J. WeNMR: structural biology on the grid. J. Grid Comput. 2012, 10:743-767.
85. Waters J., Pignatelli M., Galpin S., Ishihara K., Thomas H.C. Virus-neutralizing antibodies to hepatitis B virus: the nature of an immunogenic epitope on the S gene peptide. J. Gen. Virol. 1986, 67(Pt. 11):2467-2473.
86. Waters J.A., Brown S.E., Steward M.W., Howard C.R., Thomas H.C. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res. 1992, 22:1-12.
87. Zanetti A.R., Van Damme P., Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008, 26:6266-6273.
88. Zhang T.-Y., Yuan Q., Zhao J.-H., Zhang Y.-L., Yuan L.-Z., Lan Y., Lo Y.-C., Sun C.-P., Wu C.-R., Zhang J.-F., Zang Y., Cao J.-L., Guo X.-R., Liu X., Mo X.-B., Luo W.-X., Cheng T., Chen Y.-X., Tao M.-H., Shih J.W.K., Zhao Q.-J., Zhang J., Chen P.-J., Yuan Y.A., Xia N.S. Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen. Gut 2015, 1-14.
89. Zondlo N.J. Aromatic-proline interactions: electronically tunable CH/π interactions. Acc. Chem. Res. 2013, 46:1039-1049.
90. Zuckerman J.N., Zuckerman A.J. Current topics in hepatitis B. J. Infect. 2000, 41:130-136.
91. Zuckerman J., Zuckerman A. Mutations of the surface protein of hepatitis B virus. Antiviral Res. 2003, 60:75-78.
92. Zvirbliene A., Kucinskaite-Kodze I., Razanskiene A., Petraityte-Burneikiene R., Klempa B., Ulrich R.G., Gedvilaite A. The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody. Viruses 2014, 6:640-660.
93. Zvirbliene A., Pleckaityte M., Lasickiene R., Kucinskaite-Kodze I., Zvirblis G. Production and characterization of monoclonal antibodies against vaginolysin: mapping of a region critical for its cytolytic activity. Toxicon 2010, 56:19-28.